Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...
PharmiWeb12d
Therapeutic Plasma Exchange Market to Reach $2.9 Billion by 2031, 7.5% CAGR Driven by Autoimmune & Neurological Disorder Treatments - TMR
The global Therapeutic Plasma Exchange Market, valued at US$ 1.5 billion in 2022, is projected to grow at a compound annual ...
rarediseaseadvisor27d
Plasmapheresis: A Promising Approach for Managing Severe Rh Incompatibility
Although plasmapheresis showed promise as a treatment to mitigate the risks for severe HDFN, the current study underscored the importance of close monitoring due to potential complications such as ...